Safety and efficacy of cabozantinib for metastatic nonclear renal cell carcinoma: Real-world data from an Italian managed access program

M. Prisciandaro, R. Ratta, F. Massari, G. Fornarini, S. Caponnetto, R. Iacovelli, U. De Giorgi, G. Facchini, S. Scagliarini, R. Sabbatini, C. Caserta, G. Peverelli, A. Mennitto, E. Verzoni, G. Procopio

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)42-45
Number of pages4
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume42
Issue number1
DOIs
Publication statusPublished - 2019

Cite this

Safety and efficacy of cabozantinib for metastatic nonclear renal cell carcinoma: Real-world data from an Italian managed access program. / Prisciandaro, M.; Ratta, R.; Massari, F.; Fornarini, G.; Caponnetto, S.; Iacovelli, R.; De Giorgi, U.; Facchini, G.; Scagliarini, S.; Sabbatini, R.; Caserta, C.; Peverelli, G.; Mennitto, A.; Verzoni, E.; Procopio, G.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 42, No. 1, 2019, p. 42-45.

Research output: Contribution to journalArticle

Prisciandaro, M, Ratta, R, Massari, F, Fornarini, G, Caponnetto, S, Iacovelli, R, De Giorgi, U, Facchini, G, Scagliarini, S, Sabbatini, R, Caserta, C, Peverelli, G, Mennitto, A, Verzoni, E & Procopio, G 2019, 'Safety and efficacy of cabozantinib for metastatic nonclear renal cell carcinoma: Real-world data from an Italian managed access program', American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 42, no. 1, pp. 42-45. https://doi.org/10.1097/COC.0000000000000478
Prisciandaro, M. ; Ratta, R. ; Massari, F. ; Fornarini, G. ; Caponnetto, S. ; Iacovelli, R. ; De Giorgi, U. ; Facchini, G. ; Scagliarini, S. ; Sabbatini, R. ; Caserta, C. ; Peverelli, G. ; Mennitto, A. ; Verzoni, E. ; Procopio, G. / Safety and efficacy of cabozantinib for metastatic nonclear renal cell carcinoma: Real-world data from an Italian managed access program. In: American Journal of Clinical Oncology: Cancer Clinical Trials. 2019 ; Vol. 42, No. 1. pp. 42-45.
@article{6a5d9d871ad44d5bb43bff5f66229589,
title = "Safety and efficacy of cabozantinib for metastatic nonclear renal cell carcinoma: Real-world data from an Italian managed access program",
author = "M. Prisciandaro and R. Ratta and F. Massari and G. Fornarini and S. Caponnetto and R. Iacovelli and {De Giorgi}, U. and G. Facchini and S. Scagliarini and R. Sabbatini and C. Caserta and G. Peverelli and A. Mennitto and E. Verzoni and G. Procopio",
note = "Cited By :1 Export Date: 11 April 2019",
year = "2019",
doi = "10.1097/COC.0000000000000478",
language = "English",
volume = "42",
pages = "42--45",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Safety and efficacy of cabozantinib for metastatic nonclear renal cell carcinoma: Real-world data from an Italian managed access program

AU - Prisciandaro, M.

AU - Ratta, R.

AU - Massari, F.

AU - Fornarini, G.

AU - Caponnetto, S.

AU - Iacovelli, R.

AU - De Giorgi, U.

AU - Facchini, G.

AU - Scagliarini, S.

AU - Sabbatini, R.

AU - Caserta, C.

AU - Peverelli, G.

AU - Mennitto, A.

AU - Verzoni, E.

AU - Procopio, G.

N1 - Cited By :1 Export Date: 11 April 2019

PY - 2019

Y1 - 2019

U2 - 10.1097/COC.0000000000000478

DO - 10.1097/COC.0000000000000478

M3 - Article

VL - 42

SP - 42

EP - 45

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 1

ER -